Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.
2.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
3.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
4.

Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis.

Hemels ME, Einarson A, Koren G, Lanctôt KL, Einarson TR.

Ann Pharmacother. 2005 May;39(5):803-9. Epub 2005 Mar 22. Review.

PMID:
15784808
5.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
6.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
7.

[Pharmacologic therapy of depression during pregnancy].

Bellantuono C, Migliarese G, Imperadore G.

Recenti Prog Med. 2006 Feb;97(2):94-107. Review. Italian.

PMID:
16671276
8.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
9.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
10.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
11.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
12.

Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.

Bellantuono C, Migliarese G, Gentile S.

Hum Psychopharmacol. 2007 Apr;22(3):121-8. Review. Erratum in: Hum Psychopharmacol. 2007 Aug;22(6):413.

PMID:
17397101
13.

Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.

Rahimi R, Nikfar S, Abdollahi M.

Reprod Toxicol. 2006 Nov;22(4):571-5. Epub 2006 May 23. Review.

PMID:
16720091
14.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
15.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics..

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
16.

Review of the efficacy and safety of antidepressants in youth depression.

Cheung AH, Emslie GJ, Mayes TL.

J Child Psychol Psychiatry. 2005 Jul;46(7):735-54. Review.

PMID:
15972068
17.

Antidepressants in pregnancy: a review of commonly prescribed medications.

Patil AS, Kuller JA, Rhee EH.

Obstet Gynecol Surv. 2011 Dec;66(12):777-87. doi: 10.1097/OGX.0b013e31823e0cbf. Review.

PMID:
22192462
19.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
20.

Supplemental Content

Support Center